1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis, Lancet. 378 (2011) 1949-1961.
2. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus, Chest.132 (2007) 1311-1321.
3. Blaauboer ME, Emson CL, Verschuren L, van Erk M, Turner SM, Everts V, Hanemaaijer R, Stoop R. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways, Matrix. Biol. 32 (2013) 32 424-431.
4. Kage H, Borok Z. EMT and interstitial lung disease: a mysterious relationship, Curr. Opin. Pulm. Med. 18(2012) 517-523.
5. Liu D, Gong L, Pu S, Wu Y, Zhang W, Huang G. Histone deacetylases promote ER stress induced epithelial mesenchymal transition in human lung epithelial cells, Cell. Physiol. Biochem.46(2018) 1821-1834.
6. Miura Y, Hagiwara N, Radisky DC. Hirai Y. CCAAT/enhancer binding protein beta (C/EBPβ) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells, Exp. Cell. Res.327 (2014) 146-155.
7. Hu B, Wu Z, Phan SH. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression, Am. J. Respir. Cell. Mol. Biol. 29 (2003):397-404.
8. Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung, Proc. Am. Thorac. Soc.3(2006) 377-382.
9. Liu YY, Shi Y, Liu Y, Pan XH, Zhang KX. Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis, Acta. Pharmacol. Sin.39(2018) 39 1735-1745.
10. Wang J, He F, Chen L, Li Q, Jin S, Zheng H, Lin J, Zhang H, Ma S, Mei J, Yu J. Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways, Biomed. Pharmacothe.105(2018) 37-44.
11. Saito S, Zhuang Y, Shan B, Danchuk S, Luo F, Korfei M, Guenther A, Lasky JA. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway, PloS. One.12 (2017) e0186615.
12. Mori M, Bjermer L, Erjefält JS, Stampfli MR, Roos AB. Small airway epithelial-C/EBPβ is increased in patients with advanced COPD, Respir. Res.16(2015) 133.
13. Zhou S, Dewille JW. Proteasome-mediated CCAAT/enhancer-binding protein delta (C/EBPdelta) degradation is ubiquitin-independent, Biochem. J.405(2017) 341-349.
14. Shu S, Xu Y, Xie L, Ouyang Y. The role of C/EBPβ phosphorylation in modulating membrane phospholipids repairing in LPS-induced human lung/bronchial epithelial cells, Gene.629(2017) 76-85.
15. Hu B, Ullenbruch MR, Jin H, Gharaee-Kermani M, Phan SH. An essential role for CCAAT/enhancer binding protein beta in bleomycin induced pulmonary fibrosis, J. Pathol.211(2007) 455–462.
16. Hu B, Wu Z, Nakashima T,Phan SH. Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis, Am. J. Pathol.180(2012) 2257-2267.
17. Metz R, Ziff E. cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription, Genes. Dev.5(1991) 1754-1766.
18. Ceseña TI, Cardinaux JR, Kwok R, Schwartz J. CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription, J. Biol. Chem.282(2007) 956-967.
19. Zahnow CA. CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases, Expert. Rev. Mol. Med.8(2019) e12.
20. Ding H, Ji X, Chen R, Ma T, Tang Z, Fen Y, Cai H. Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis, Pulm. Pharmacol. Ther.35 (2015) 34-41.
21. Chen JY, Lin CH, Chen BC. Hypoxia-induced ADAM 17 expression is mediated by RSK1-dependent C/EBPβ activation in human lung fibroblasts, Mol. Immunol.88(2017) 155-163.
22. Miyazaki S, Kakutani K, Yurube T, Maeno K, Takada T, Zhang Z, Kurakawa T, Terashima Y, Masaaki Ito M, Ueha T, Matsushita T, Kuroda R, Kurosaka M, Nishida K. Recombinant human SIRT1 protects against nutrient deprivation-induced mitochondrial apoptosis through autophagy induction in human intervertebral disc nucleus pulposus cells, Arth. Res. Ther.17(2015) 253-265.
23. Peixoto P, Etcheverry A, Aubry M, Missey A, Lachat C, Perrard J, Hendrick E, Delage-Mourroux R, Mosser J, Borg C, Feugeas JP, Herfs M, Boyer-Guittaut M and Hervouet E. EMT is associated with an epigenetic signature of ECM remodeling genes, Cell. Death. Disease.10(2019) 205.
24. Buck M, Chojkier M. C/EBPβ-Thr217 phosphorylation signaling contributes to the development of lung injury and fibrosis in mice, Plos. One.6(2011) e25497.
25 Klymenko O, Huehn M, Wilhelm J, Wasnick R, Shalashova I, Ruppert C, Henneke I, Hezel S, Guenther K, Mahavadi P, Samakovlis C, Seeger W, Guenther A, Korfei M. Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells, J. Mol. Med. (Berl) 97(2019) 973-990.
26 Shi ZL. Xu LH, Xie H, Ouyang RY, Ke Y, Zhou R, Yung WH. Attenuation of intermittent hypoxia-induced apoptosis and fibrosis in pulmonary tissues via suppression of ER stress activation, BMC. Pulm. Med.20(2020) 92.
27 Abdesselem H, Madani A, Hani A, Al-Noubi M, Goswami N, Ben Hamidane H, Billing AM, Pasquier J, Bonkowski MS, Halabi N, Dalloul R, Sheriff MZ, Mesaeli N, ElRayess M, Sinclair DA, Graumann J, Mazloum NA. SIRT1 limits adipocyte hyperplasia through c-Myc inhibition, J. Biol. Chem.291(2016) 2119-2135.
28 Hill C, Jones MG, Davies DE, Wang Y. Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk, J. Lung. Health. Dis.3(2019) 31-35.
29 Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, Jackson AL, Nikolinakos P, Ospina B, Naumov G, Brandstetter KA, Weigman VJ, Zaghlul S, Hayes DN, Padera RF, Heymach JV, Kung AL, Sharpless NE, Kaelin WG Jr, Wong KK. The basics of epithelial-mesenchymal transition, J. Clin. Invest.119(2009) 1420-1428.
30 Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition, Nat. Rev. Mol. Cell. Biol.15(2014) 178-196.
31 Michael S, Nicole H, Silvia L, Alois F, Ekkehard J, Gerhard R. Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis, Clin. Transl. Med.4(2015) 1.
32 Ma WH, Li M, Ma HF, Li W, Liu L, Yin Y, Zhou XM, Hou G. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways, Life. Sci.241(2020) 117139.
33. Cai Y, Hirata A, Nakayama S, VanderLaan PA, Levantini E, Yamamoto M, Hirai H, Wong KK, Costa DB, Watanabe H, Kobayashi SS. CCAAT/Enhancer binding protein β is dispensable for development of lung adenocarcinoma, Plos. One.10(2015) e0120647.
34. Sun Q, Fang L, Tang X, Lu S, Tamm M, Stolz D, Roth M. TGF-β upregulated mitochondria mass through the SMAD2/3→C/EBPβ→PRMT1 signal pathway in primary human lung fibroblasts, J. Immuno.202(2019) 37-47.
35. Takayama K, Kawabata K, Nagamoto Y, Inamura M, Ohashi K, Okuno H, Yamaguchi T, Tashiro K, Sakurai F, Hayakawa T, Okano T, Furue MK, Mizuguchi H. CCAAT/enhancer binding protein-mediated regulation of TGF-β receptor 2 expression determines the hepatoblast fate decision, Development.141(2014) 91-100.
36. Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer, Oncogene.32(2013) 5614-5624.
37. Hu B, Wu Z, Jin H, Hashimoto N, Liu T, Phan SH. CCAAT/enhancer-binding protein beta isoforms and the regulation of alpha-smooth muscle actin gene expression by IL-1 beta, J. Immunol.173(2004) 4661-4668.
38. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes, Cell.138(2009) 1019-1031.
39. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy, Nat. Rev. Genet.10(2009) 32-42.
40. Huang ZW, Lien GS, Lin CH, Jiang CP, Chen BC. p300 and C/EBPβ-regulated IKKβ expression are involved in thrombin-induced IL-8/CXCL8 expression in human lung epithelial cells, Pharmacol. Res.121(2017) 33-41.
41. Yanagisawa S, Baker JR, Vuppusetty C, Koga T, Colley T, Fenwick P, Donnelly LE, Barnes PJ, Ito K. The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure, Plos. One.13(2018) e0193921.
42. E Batlle, E Sancho, C Francí, D Domínguez, M Monfar, J Baulida, A. García de Herreros. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells, Nat. Cell. Biol.2(2020) 84-89.
43. Savagner P, Yamada KM, Thiery JP. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition, J. Cell. Biol.137(1997) 1403-1419.
44. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis, Cell.117(2004) 927-939.